XML 40 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation Plans (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Stock Option Activity

A summary of option activity for the three months ended March 31, 2025 is presented below:

 

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2024

 

 

5,242,916

 

 

$

28.76

 

 

 

 

 

 

 

Granted

 

 

90,134

 

 

 

3.04

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(40,423

)

 

 

20.82

 

 

 

 

 

 

 

Expired

 

 

(99,463

)

 

 

76.90

 

 

 

 

 

 

 

Outstanding at March 31, 2025

 

 

5,193,164

 

 

$

27.42

 

 

 

7.93

 

 

$

 

Vested or expected to vest at March 31, 2025

 

 

5,193,164

 

 

$

27.42

 

 

 

7.93

 

 

$

 

Exercisable at March 31, 2025

 

 

2,711,308

 

 

$

46.08

 

 

 

6.61

 

 

$

 

Summary of Non-vested Stock Activity

A summary of non-vested stock activity for the three months ended March 31, 2025 is presented below:

 

 

Non-vested
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Outstanding at December 31, 2024

 

 

42,222

 

 

$

17.30

 

Granted

 

 

77,551

 

 

 

2.69

 

Vested

 

 

(69,325

)

 

 

3.63

 

Forfeited

 

 

(6,333

)

 

 

21.25

 

Outstanding at March 31, 2025

 

 

44,115

 

 

$

12.52

 

Schedule of Share-Based Compensation Expense

The impact on our results of operations from share-based compensation for the three months ended March 31, 2025 and 2024, was as follows (in thousands):

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

826

 

 

$

1,314

 

General and administrative

 

 

2,507

 

 

 

2,882

 

Total share-based compensation expense

 

$

3,333

 

 

$

4,196